Sabiha Naim Qazi

Array ( [id] => 4779406 [patent_doc_number] => 20080287404 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-20 [patent_title] => 'High Purity 17Alpha-Cyanomethyl-17Beta-Hydroxy-Estra-4,9-Diene-3- One and Process For the Syntheses Thereof' [patent_app_type] => utility [patent_app_number] => 12/096209 [patent_app_country] => US [patent_app_date] => 2006-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3072 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20080287404.pdf [firstpage_image] =>[orig_patent_app_number] => 12096209 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8232823 [patent_doc_number] => 08198263 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-12 [patent_title] => 'Vitamin D derivatives active on the vitamin D nuclear receptor, preparation and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/088413 [patent_app_country] => US [patent_app_date] => 2006-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 12242 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/198/08198263.pdf [firstpage_image] =>[orig_patent_app_number] => 12088413 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5304148 [patent_doc_number] => 20090298800 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => '1,25-DIHYDROXY, 20-CYCLOPROPYL,26-27-DEUTEROALKYL VITAMIN D3 COMPOUNDS AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/067873 [patent_app_country] => US [patent_app_date] => 2006-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31242 [patent_no_of_claims] => 75 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20090298800.pdf [firstpage_image] =>[orig_patent_app_number] => 12067873 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5205638 [patent_doc_number] => 20070027120 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-01 [patent_title] => 'Methods of using vitamin D compounds in the treatment of myelodysplastic syndromes' [patent_app_type] => utility [patent_app_number] => 11/516776 [patent_app_country] => US [patent_app_date] => 2006-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 31282 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20070027120.pdf [firstpage_image] =>[orig_patent_app_number] => 11516776 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4972074 [patent_doc_number] => 20070112077 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-17 [patent_title] => 'Des-C,D analogs of 1alpha,25-dihydroxy-19-norvitamin D3' [patent_app_type] => utility [patent_app_number] => 11/512705 [patent_app_country] => US [patent_app_date] => 2006-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11065 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20070112077.pdf [firstpage_image] =>[orig_patent_app_number] => 11512705 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5564975 [patent_doc_number] => 20090137828 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'Synthesis of 1A-Fluoro-25-Hydroxy-16-23E-Diene-26,27-Bishomo-20-Epi-Cholecalciferol' [patent_app_type] => utility [patent_app_number] => 12/063955 [patent_app_country] => US [patent_app_date] => 2006-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22459 [patent_no_of_claims] => 74 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20090137828.pdf [firstpage_image] =>[orig_patent_app_number] => 12063955 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5575980 [patent_doc_number] => 20090143342 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => '26,27-homologated-20-EPI-2-alkylidene-19-nor-vitamin D compounds' [patent_app_type] => utility [patent_app_number] => 11/507092 [patent_app_country] => US [patent_app_date] => 2006-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14598 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20090143342.pdf [firstpage_image] =>[orig_patent_app_number] => 11507092 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5609329 [patent_doc_number] => 20060270845 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-30 [patent_title] => '16-Hydroxyestratrienes as selectively active estrogens' [patent_app_type] => utility [patent_app_number] => 11/498109 [patent_app_country] => US [patent_app_date] => 2006-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21910 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20060270845.pdf [firstpage_image] =>[orig_patent_app_number] => 11498109 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6039499 [patent_doc_number] => 20110092548 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => 'METHOD FOR TREATING/PREVENTING DISEASE USING COGNITIVE ABILITY OF CEREBRUM AND PHARMACEUTICAL' [patent_app_type] => utility [patent_app_number] => 12/295139 [patent_app_country] => US [patent_app_date] => 2006-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14623 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20110092548.pdf [firstpage_image] =>[orig_patent_app_number] => 12295139 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4983448 [patent_doc_number] => 20070088007 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-19 [patent_title] => 'Method for preparing analogue of vitamin D' [patent_app_type] => utility [patent_app_number] => 11/477698 [patent_app_country] => US [patent_app_date] => 2006-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7634 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20070088007.pdf [firstpage_image] =>[orig_patent_app_number] => 11477698 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5924176 [patent_doc_number] => 20060241090 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-26 [patent_title] => 'Use of 2-methylene-19-nor-20(S)-1alpha,25dihydroxyvitamin D3 to increase the life expectancy of human beings' [patent_app_type] => utility [patent_app_number] => 11/472125 [patent_app_country] => US [patent_app_date] => 2006-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2625 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20060241090.pdf [firstpage_image] =>[orig_patent_app_number] => 11472125 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5929856 [patent_doc_number] => 20110039815 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-17 [patent_title] => 'MACROCYCLIC METAL COMPLEXES FOR THEIR USE AS ANTICANCER AGENTS' [patent_app_type] => utility [patent_app_number] => 11/917660 [patent_app_country] => US [patent_app_date] => 2006-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 4239 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20110039815.pdf [firstpage_image] =>[orig_patent_app_number] => 11917660 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4971971 [patent_doc_number] => 20070111974 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-17 [patent_title] => 'Therapeutic gestagens for the treatment of premenstrual dysphoric disorder' [patent_app_type] => utility [patent_app_number] => 11/449866 [patent_app_country] => US [patent_app_date] => 2006-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2355 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20070111974.pdf [firstpage_image] =>[orig_patent_app_number] => 11449866 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5279582 [patent_doc_number] => 20090131714 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-21 [patent_title] => 'SYNTHESIS OF BETULONIC AND BETULINIC ALDEHYDES' [patent_app_type] => utility [patent_app_number] => 11/917105 [patent_app_country] => US [patent_app_date] => 2006-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6540 [patent_no_of_claims] => 73 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20090131714.pdf [firstpage_image] =>[orig_patent_app_number] => 11917105 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5754660 [patent_doc_number] => 20060223809 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-05 [patent_title] => 'Novel compounds' [patent_app_type] => utility [patent_app_number] => 11/447343 [patent_app_country] => US [patent_app_date] => 2006-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14775 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20060223809.pdf [firstpage_image] =>[orig_patent_app_number] => 11447343 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5149502 [patent_doc_number] => 20070049562 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-01 [patent_title] => 'Tigecycline and methods of preparation' [patent_app_type] => utility [patent_app_number] => 11/440035 [patent_app_country] => US [patent_app_date] => 2006-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 24746 [patent_no_of_claims] => 72 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20070049562.pdf [firstpage_image] =>[orig_patent_app_number] => 11440035 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5149500 [patent_doc_number] => 20070049560 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-01 [patent_title] => 'Tigecycline and methods of preparing 9-nitrominocycline' [patent_app_type] => utility [patent_app_number] => 11/440031 [patent_app_country] => US [patent_app_date] => 2006-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 24743 [patent_no_of_claims] => 76 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20070049560.pdf [firstpage_image] =>[orig_patent_app_number] => 11440031 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5149501 [patent_doc_number] => 20070049561 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-01 [patent_title] => 'Methods of purifying tigecycline' [patent_app_type] => utility [patent_app_number] => 11/440034 [patent_app_country] => US [patent_app_date] => 2006-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 24745 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20070049561.pdf [firstpage_image] =>[orig_patent_app_number] => 11440034 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10141048 [patent_doc_number] => 09173835 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-03 [patent_title] => 'Compositions and methods for treating hyperproliferative epidermal diseases' [patent_app_type] => utility [patent_app_number] => 11/914102 [patent_app_country] => US [patent_app_date] => 2006-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 15952 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11914102 [rel_patent_id] =>[rel_patent_doc_number] =>)